Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)Contributed by: Business WireLogoTagsHealthClinical TrialsResearchSciencePharmaceuticalOpticalBiotechnologyNJCTTQ, NTB003, IND approval